Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,213.80
Bid: 1,213.60
Ask: 1,214.00
Change: 6.00 (0.50%)
Spread: 0.40 (0.03%)
Open: 1,207.00
High: 1,218.80
Low: 1,204.00
Yest. Close: 1,207.80
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

CORRECT: GlaxoSmithKline Chief Strategy Officer Associate Sells Shares

LONDON (Alliance News) - GloxoSmithKline PLC said that a person closely associated with Chief Strategy Officer David Redfern disposed 3,930 shares in the company at 1,575 pence each in two on up

31 Jul 18 17:52

DIRECTOR DEALING: GlaxoSmithKline Chief Strategy Associate Buys Shares

LONDON (Alliance News) - GloxoSmithKline PLC said that a person closely associated with Chief Strategy Officer David Redfern bought 3,930 shares in the company at 1,575 pence each in two on shares

31 Jul 18 17:51

GSK Gets Committee Approval For Nucala In Paediatric Patients

LONDON (Alliance News) - FTSE 100 pharma company GlaxoSmithKline PLC said Friday a European Medicines Agency committee has recommended its asthma drug Nucala for patients between six and 17 years

27 Jul 18 15:47

PRESS: Former HSBC CFO In Bid For GSK Finance Chief Position - Sky

LONDON (Alliance News) - Former HSBC Holdings PLC Finance Director Iain Mackay is currently in the running to become chief financial officer of FTSE 100-listed pharmaceutical giant GlaxoSmithKline

27 Jul 18 15:17

Thursday broker round-up

(Sharecast News) - Beazley: Berenberg upgrades to buy with a target price of 640p.

26 Jul 18 13:01

LONDON MARKET MIDDAY: Stocks Flat Amid Results Deluge Ahead Of ECB

LONDON (Alliance News) - Stock prices in London were flat at midday as investors absorbed Thursday's bounty of company results.Gains for reporting firms British America Tobacco,

26 Jul 18 12:04

WINNERS & LOSERS SUMMARY: BAT On Fire After Half Year Earnings Surge

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - WINNERS----------British up a

26 Jul 18 10:55

TOP NEWS: Glaxo Says US Panel Voted Against Mepolizumab For COPD

LONDON (Alliance News) - GlaxoSmithKline PLC said Thursday an advisory panel of US Food & Drug Administration has recommended against approval of mepolizumab for the treatment of chronic a of

26 Jul 18 08:44

GlaxoSmithKline's COPD biologic rejected by FDA advisory board

(Sharecast News) - GlaxoSmithKline's application to market a new biologic drug for chronic obstructive pulmonary disease has been rejected by the advisory board of the US medical watchdog, though the company remains confident in the drug as a COPD treatment.

26 Jul 18 08:16

EXTRA: GlaxoSmithKline Lifts Outlook, Partners On Genetic Profiling

LONDON (Alliance News) - GlaxoSmithKline said Wednesday it is taking new approach to research & development by partnering with genetic profiling company 23andMe Inc, as it reported a strong of

25 Jul 18 13:54

TOP NEWS: GlaxoSmithKline Upgrades Outlook On Strong First Half

LONDON (Alliance News) - GlaxoSmithKline PLC on Wednesday posted a rise in first half profit due to strong performance of its new shingles drug.In the first half ended June 30, the pretax a

25 Jul 18 12:13

LONDON MARKET MIDDAY: Fresnillo Falls While Housebuilders, GSK Rise

LONDON (Alliance News) - Stocks continued to trade mostly lower at midday on Wednesday, with focus on a meeting between the European Commission president and US president amid escalating global trade

25 Jul 18 11:59

GSK bets $300m on tie-up with gene-tester 23andMe

(Sharecast News) - GlaxoSmithKline has invested $300m (£228m) in 23andMe, a Silicon Valley gene-testing company, as the UK drugs giant looks to genetics to improve growth in its pharmaceuticals division.

25 Jul 18 11:06

GSK to apply for new two-drug HIV combo after Gemini trial success

(Sharecast News) - Glaxosmithkline's ViiV Healthcare joint venture reported positive results from trials of two of its key HIV treatments on Tuesday.

24 Jul 18 10:15

GlaxoSmithKline Says ViiV HIV Two-Drug Regimen Meets Primary Endpoint

LONDON (Alliance News) - GlaxoSmithKline PLC said Tuesday its joint venture ViiV Healthcare's two-drug regimen for the treatment of HIV met its primary endpoint in two studies.The FTSE

24 Jul 18 09:27

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.